This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered In-Person & Digitally
March 28–30, 2022, Basel, SwitzerlandApril 4–6, 2022, Digital Partnering

Stimunity

Profile

France

Stimunity develops immuno-stimulatory biological drugs in oncology. The company is a spin-off of Institut Curie (Paris, France) exploiting a Virus-Like Particle cutting-edge technology to stimulate the immune system against tumor cells via the STING pathway. Unlike competition, we achieve a potent immune response, a synergy with immune checkpoint inhibitors and a therapeutic efficacy on distant tumors.

Presenter: Sylvain Carlioz, CEO, Stimunity